Literature DB >> 21764192

Telomere biology in hematopoiesis and stem cell transplantation.

Shahinaz M Gadalla1, Sharon A Savage.   

Abstract

Telomeres are long (TTAGGG)(n) nucleotide repeats and an associated protein complex located at the end of the chromosomes. They shorten with every cell division and, thus are markers for cellular aging, senescence, and replicative capacity. Telomere dysfunction is linked to several bone marrow disorders, including dyskeratosis congenita, aplastic anemia, myelodysplastic syndrome, and hematopoietic malignancies. Hematopoietic stem cell transplantation (HSCT) provides an opportunity in which to study telomere dynamics in a high cell proliferative environment. Rapid telomere shortening of donor cells occurs in the recipient shortly after HSCT; the degree of telomere attrition does not appear to differ by graft source. As expected, telomeres are longer in recipients of grafts with longer telomeres (e.g., cord blood). Telomere attrition may play a role in, or be a marker of, long term outcome after HSCT, but these data are limited. In this review, we discuss telomere biology in normal and abnormal hematopoiesis, including HSCT. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21764192      PMCID: PMC7737640          DOI: 10.1016/j.blre.2011.06.004

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  155 in total

1.  Telomere maintenance in human B lymphocytes.

Authors:  Uwe M Martens; Volker Brass; Lucie Sedlacek; Milena Pantic; Carolin Exner; Yalin Guo; Monika Engelhardt; Peter M Lansdorp; Cornelius F Waller; Winand Lange
Journal:  Br J Haematol       Date:  2002-12       Impact factor: 6.998

Review 2.  Changes of telomere length with aging.

Authors:  Kaiyo Takubo; Junko Aida; Naotaka Izumiyama-Shimomura; Naoshi Ishikawa; Motoji Sawabe; Rie Kurabayashi; Hiroaki Shiraishi; Tomio Arai; Ken-Ichi Nakamura
Journal:  Geriatr Gerontol Int       Date:  2010-07       Impact factor: 2.730

3.  Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita.

Authors:  Mohamad M Al-Rahawan; Neelam Giri; Blanche P Alter
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

Review 4.  Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.

Authors:  Gunhild Keller; Ute Brassat; Melanie Braig; Denise Heim; Henning Wege; Tim H Brümmendorf
Journal:  Hematol Oncol       Date:  2009-09       Impact factor: 5.271

5.  Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives.

Authors:  Shiran Yehezkel; Annie Rebibo-Sabbah; Yardena Segev; Maty Tzukerman; Rony Shaked; Irit Huber; Lior Gepstein; Karl Skorecki; Sara Selig
Journal:  Epigenetics       Date:  2011-01-01       Impact factor: 4.528

6.  Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study.

Authors:  Rochelle E Curtis; Catherine Metayer; J Douglas Rizzo; Gérard Socié; Kathleen A Sobocinski; Mary E D Flowers; William D Travis; Lois B Travis; Mary M Horowitz; H Joachim Deeg
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

7.  Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression.

Authors:  K Ohyashiki; J H Ohyashiki; H Iwama; S Hayashi; J W Shay; K Toyama
Journal:  Leukemia       Date:  1997-02       Impact factor: 11.528

Review 8.  New developments in telomere length analysis.

Authors:  Duncan M Baird
Journal:  Exp Gerontol       Date:  2005-03-29       Impact factor: 4.032

9.  Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss.

Authors:  Ian Thornley; Robert Sutherland; Robert Wynn; Rakash Nayar; Lillian Sung; George Corpus; Thomas Kiss; Jeff Lipton; John Doyle; Fred Saunders; Suzanne Kamel-Reid; Melvin Freedman; Hans Messner
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

10.  Telomere dynamics in human cells reprogrammed to pluripotency.

Authors:  Steven T Suhr; Eun Ah Chang; Ramon M Rodriguez; Kai Wang; Pablo J Ross; Zeki Beyhan; Shashanka Murthy; Jose B Cibelli
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more
  22 in total

1.  Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.

Authors:  Shahinaz M Gadalla; Tao Wang; Michael Haagenson; Stephen R Spellman; Stephanie J Lee; Kirsten M Williams; Jason Y Wong; Immaculata De Vivo; Sharon A Savage
Journal:  JAMA       Date:  2015-02-10       Impact factor: 56.272

2.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Authors:  Lindsay M Morton; Wael Saber; K Scott Baker; A John Barrett; Smita Bhatia; Eric A Engels; Shahinaz M Gadalla; David E Kleiner; Steven Pavletic; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

3.  Telomere length in hematopoietic cell transplant.

Authors:  Shahinaz M Gadalla
Journal:  Blood       Date:  2020-12-24       Impact factor: 22.113

4.  Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation.

Authors:  Régis Peffault de Latour; Rodrigo T Calado; Marc Busson; Jeffrey Abrams; Nadir Adoui; Marie Robin; Jérôme Larghero; Nathalie Dhedin; Alienor Xhaard; Emmanuel Clave; Dominique Charron; Antoine Toubert; Pascale Loiseau; Gérard Socié; Neal S Young
Journal:  Blood       Date:  2012-09-04       Impact factor: 22.113

5.  Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes.

Authors:  Yogen Saunthararajah; Mikkael Sekeres; Anjali Advani; Reda Mahfouz; Lisa Durkin; Tomas Radivoyevitch; Ricki Englehaupt; Joy Juersivich; Kathleen Cooper; Holleh Husseinzadeh; Bartlomiej Przychodzen; Matthew Rump; Sean Hobson; Marc Earl; Ronald Sobecks; Robert Dean; Frederic Reu; Ramon Tiu; Betty Hamilton; Edward Copelan; Alan Lichtin; Eric Hsi; Matt Kalaycio; Jaroslaw Maciejewski
Journal:  J Clin Invest       Date:  2015-01-26       Impact factor: 14.808

Review 6.  The complex pathophysiology of acquired aplastic anaemia.

Authors:  Y Zeng; E Katsanis
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

7.  The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the Literature.

Authors:  Lisa Gallicchio; Shahinaz M Gadalla; John D Murphy; Naoko I Simonds
Journal:  J Natl Cancer Inst       Date:  2018-10-01       Impact factor: 13.506

Review 8.  Telomere shortening in neurological disorders: an abundance of unanswered questions.

Authors:  Erez Eitan; Emmette R Hutchison; Mark P Mattson
Journal:  Trends Neurosci       Date:  2014-03-31       Impact factor: 13.837

9.  A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Adam S Nelson; Rebecca A Marsh; Kasiani C Myers; Stella M Davies; Sonata Jodele; Tracey A O'Brien; Parinda A Mehta
Journal:  Biol Blood Marrow Transplant       Date:  2016-02-01       Impact factor: 5.742

Review 10.  Telomere Length and Hematological Disorders: A Review.

Authors:  Beatriz Maria Dias Nogueira; Caio Bezerra Machado; Raquel Carvalho Montenegro; Maria Elisabete Amaral DE Moraes; Caroline Aquino Moreira-Nunes
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.